The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Hepatitis C Virus Infection Associated with Rheumatoid Arthritis

Hepatitis C Virus Infection Associated with Rheumatoid Arthritis

January 23, 2015 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Approximately 130 million people worldwide are infected with hepatitis C virus (HCV). Although HCV primarily damages the liver, infection also causes multiple extrahepatic manifestations, including elicitation of autoimmune reaction, deposition of immune complexes and/or lymphoproliferation. Some patients develop arthritis, and many patients with HCV-related polyarthritis also meet the American College of Rheumatology criteria for rheumatoid arthritis (RA). Consequently, clinicians have noted an association between rheumatic diseases and chronic HCV infection. It has been difficult, however, to document this association in research studies.

You Might Also Like
  • Hepatitis-C Virus–Associated Arthritis
  • Hepatitis Virus, Rheumatic Disease Connection Explored
  • Hepatitis Reaction with Rituximab Sparks Drug Safety Alert
Also By This Author
  • Atherosclerosis, Cardiovascular Disease More Common in Patients with Primary Sjögren’s Syndrome

In a recently published study in PLoSOne, investigators Fu-Hsiung Su, MBBS, PhD, and colleagues describe their research to assess the risk of developing RA among patients with chronic HCV infection.1 The researchers studied patients in Taiwan, a country with a high prevalence of both HCV and hepatitis B virus (HBV) infections, as well as RA (52.4 per 100,000).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Su, an attending physician and assistant professor of Taipei Medical University in Taiwan, extracted data from the National Health Insurance Research Database, which includes 1 million patients randomly selected from all insured enrollees in Taiwan, and performed a nationwide population-based cohort study.

The investigators identified 249,460 patients with data from 2000–2011 for analysis. Of these, 49,892 patients had been diagnosed with chronic hepatitis virus infection: 10,253 had chronic HCV infection, 35,652 had chronic HBV infection alone, and 3,987 had chronic HCV/HBV dual infection.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Patients with the hepatitis virus were compared with 199,568 individuals who were matched for age, sex and calendar year, but did not have chronic hepatitis virus infection. The patients did not have a diagnosis of RA at baseline. The investigators noted any diagnosis of RA that occurred through 2011.

Cases of RA were defined on the basis of International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes and their catastrophic disease registration. Impairment of liver function was also defined based on ICD-9-CM coding. The investigators did not control for family history, smoking, diet or hormone levels. They did perform bivariate statistical analysis of sex, age, geographic region, occupation, urbanization level, monthly income and Deyo’s Charlson Comorbidity Index.

After adjusting for covariates, the team found that chronic infection with HCV was associated with the development of RA (hazard ratio [HR] 2.03, 95% confidence interval [95% CI] 1.27–3.22). The increased risk remained significant even after the investigators restricted their analysis to patients who were prescribed disease-modifying antirheumatic drugs (HR 1.89, 95% CI 1.15–3.11). Men were more likely than women to have RA associated with chronic HCV infection (HR 1.88, 95% CI 1.08–3.25 for women; and HR 2.57, 95% CI 1.08–6.13 for men).

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Additionally, researchers found that patients with chronic HCV infection and HBV/HCV dual infection were more likely to have RA than patients with non-chronic HBV and HCV infections, although chronic HBV infection was not associated with a high risk of developing RA.

This latter finding stands in contrast to previous studies that suggested chronic HBV infection may trigger the development of autoimmune rheumatic diseases. The investigators did find, however, that chronic HBV infection with persistent or periodic impairment of liver function was associated with RA (HR 2.64, 95% CI 0.84–8.28). (posted 1/23/15)

Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

Reference

1. Su FH, Wu CS, Sung FC, et al. Chronic hepatitis c virus infection is associated with the development of rheumatoid arthritis: a nationwide population-based study in Taiwan. PLoSOne. 2014; 9(11): e113579.

Visit our website for more information on hepatitis and antirheumatic drugs.

Pages: 1 2 | Multi-Page

Filed Under: Conditions, Research Reviews, Rheumatoid Arthritis Tagged With: hepatitis B virus, hepatits C virus, Research, Rheumatoid arthritis

You Might Also Like:
  • Hepatitis-C Virus–Associated Arthritis
  • Hepatitis Virus, Rheumatic Disease Connection Explored
  • Hepatitis Reaction with Rituximab Sparks Drug Safety Alert
  • Rheumatoid Arthritis Patients on Biologics Remain At Risk of Infection

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)